Adaptive Biotechnologies makes immune system based cancer tests and sells immune data to clinicians and drug developers. It last closed at $27.93 on Nov 20, down 0.43% on the day. The next earnings report for ADPT is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, ADPT reported EPS of $0.02 on revenue of $83.9M, with revenue down 10.7% from a year ago. Over its last 8 reports the stock moved an average of 10.3% the session after earnings. Over the last 12 months ADPT insiders bought $0 of stock on the open market and sold $131.7M, according to SEC Form 4 filings.
AI Auto Pilots
Is ADPT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ADPT.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ADPTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ADPT · as of the Nov 20 close · updated each morning
Uptrend
The stock is 0% above its 20 day and 2% above its 50 day average. It is 27% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 52). The nearest support is the 20 day average at $27.92, and the nearest resistance the Pivot R1 at $28.39.
Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 6.1%/day
Key levels
$32.2152 week high+15.3%
$29.05Swing high (Oct 28)+4.0%
$28.39Pivot R1+1.6%
$27.93Last close
$27.9220 day average−0.0%
$27.77Pivot−0.6%
$27.31Pivot S1−2.2%
$27.2950 day average−2.3%
$27.29Swing low (Nov 16)−2.3%
$25.49100 day average−8.7%
$20.35200 day average−27.1%
$12.0052 week low−57.0%
Indicators
RSI (14)
51.55
Middle of its range
Neutral
MACD
0.53
Below its signal line
Bearish
Stochastic
44.1
Middle of its range
Neutral
ADX (14)
17.3
No clear trend
Williams %R
-61.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
-9.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−0.2%
Change over 10 sessions
Bearish
ATR (14)
$1.69
Typical daily range, 6.1% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityLow, 10.2%/day
Key levels
$32.2152 week high+15.3%
$29.05Swing high (Oct 28)+4.0%
$28.39Pivot R1+1.6%
$27.93Last close
$27.9220 day average−0.0%
$27.77Pivot−0.6%
$27.31Pivot S1−2.2%
$27.2950 day average−2.3%
$27.29Swing low (Nov 16)−2.3%
$25.49100 day average−8.7%
$20.35200 day average−27.1%
$12.0052 week low−57.0%
Indicators
RSI (14)
61.95
Strong, overbought above 70
Neutral
MACD
2.49
Below its signal line
Bearish
Stochastic
61.1
Middle of its range
Neutral
ADX (14)
38.6
Trending up
Williams %R
-49.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
93.2
Oversold below −100, overbought above 100
Neutral
Rate of change
+15.4%
Change over 10 sessions
Bullish
ATR (14)
$2.85
Typical daily range, 10.2% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for ADPT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ADPT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ADPT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ADPTHow many large options trades hit ADPT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ADPT in the last 90 days.
From SEC Form 4 filings by ADPT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ADPT is in one of them and how their past ADPT trades turned out.
Adaptive Biotechnologies is a life sciences company based in Seattle, Washington. It uses sequencing and data analysis of the immune system to develop medical tests and products. Its main product, clonoSEQ, measures residual disease in patients with blood cancers and is sold to clinicians. It also runs testing for biopharmaceutical companies developing new drugs and licenses its immune system data to drug developers.